RNA 편집 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - RNA 유형별, 용도별, 기술별, 지역별 세분화 및 경쟁 구도(2020-2030년)
RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of RNA, By Application, By Technique, By Region and Competition, 2020-2030F
상품코드:1879003
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 RNA 편집 기술 시장은 2024년에 2억 6,228만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 7.16%로 성장하여 3억 9,716만 달러에 이를 것으로 예측됩니다.
RNA 편집 기술은 전사 후 RNA 분자 내의 특정 뉴클레오티드 서열을 정밀하게 수정하는 분자 과정을 말하며, 유전체 DNA에 영구적인 변화를 주는 것과는 다릅니다. 이를 통해 치료, 연구, 진단 용도로 유전자 돌연변이의 표적 교정 및 유전자 발현 조절이 가능합니다. 시장 확대는 정밀의료에 대한 수요 증가, CRISPR 기반 RNA 편집 도구의 획기적인 발전, RNA 편집 연구에 대한 투자 확대가 주요 촉진요인으로 작용하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
2억 6,228만 달러
시장 규모 : 2030년
3억 9,716만 달러
CAGR : 2025-2030년
7.16%
성장 속도가 가장 빠른 부문
메신저 RNA 수식
최대 시장
북미
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 RNA 편집 기술 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
RNA 유형별(메신저 RNA 수식, 트랜스퍼 RNA 수식, 리보솜 RNA 수식)
용도별(암, 유전성 질환, 일시적인 질환)
기술별(삽입/삭제, 탈아미노화)
지역별
기업별(2024년)
시장 맵
제6장 북미의 RNA 편집 기술 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 RNA 편집 기술 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 RNA 편집 기술 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 RNA 편집 기술 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카공화국
제10장 남미의 RNA 편집 기술 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)
제품 출시
최근 동향
제13장 세계의 RNA 편집 기술 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
ProQR Therapeutics NV
Sirna Therapeutics, Inc.
Shape Therapeutics, Inc.
Korro Bio, Inc.
Beam Therapeutics, Inc.
QIAGEN N.V.
UniQure NV(UniQure)
LAVA Therapeutics N.V.
argenx SE
Arrowhead Pharmaceuticals, Inc.
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
The Global RNA Editing Technologies Market, valued at USD 262.28 Million in 2024, is projected to experience a CAGR of 7.16% to reach USD 397.16 Million by 2030. RNA editing technologies involve molecular processes that precisely modify specific nucleotide sequences within an RNA molecule after its transcription, distinct from permanent alterations to the genomic DNA. This enables targeted corrections of genetic mutations and modulation of gene expression for therapeutic, research, and diagnostic applications. The market's expansion is fundamentally driven by the increasing demand for precision medicine, significant advancements in CRISPR-based RNA editing tools, and growing investments in RNA editing research.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 262.28 Million
Market Size 2030
USD 397.16 Million
CAGR 2025-2030
7.16%
Fastest Growing Segment
Messenger RNA Modification
Largest Market
North America
Key Market Drivers
The global RNA editing technologies market is profoundly influenced by two pivotal factors: significant advancements in RNA editing technologies and the increasing demand for precision and personalized medicine. Ongoing innovation in advanced gene editing platforms, particularly CRISPR-based systems and enhanced delivery mechanisms, continues to broaden the therapeutic applicability of RNA editing. For instance, according to the Innovative Genomics Institute, in March 2024, the UK's Medicines and Healthcare Products Regulatory Agency approved Casgevy for sickle cell disease and transfusion-dependent beta-thalassemia in November 2023, with subsequent FDA approval for sickle cell disease in December 2023, marking the first regulatory clearances for a CRISPR-based therapy.
Key Market Challenges
The technical complexity associated with efficient delivery and precise targeting systems for RNA editing components within specific cells and tissues represents a significant impediment to market expansion. This challenge directly affects the progression and success of therapeutic development by prolonging research and development timelines and escalating costs. The difficulty in developing safe and effective methods to introduce RNA editing tools precisely into target cells, without off-target effects or degradation, limits the scalability and broad application of these advanced therapies.
Key Market Trends
Increased cross-sectoral collaborations and partnerships are significantly driving growth in the Global RNA Editing Technologies Market by fostering shared expertise and resources. These alliances between biotechnology firms, pharmaceutical companies, and academic institutions accelerate the complex research and development cycle of RNA editing solutions. For example, in September 2024, Prime Medicine announced a strategic research collaboration and license agreement with Bristol Myers Squibb, which included a $55 million upfront payment and a $55 million equity investment, to develop ex vivo T-cell therapies using Prime Editing technology, demonstrating significant financial commitment to such joint ventures.
Key Market Players
ProQR Therapeutics NV
Sirna Therapeutics, Inc.
Shape Therapeutics, Inc.
Korro Bio, Inc.
Beam Therapeutics, Inc.
QIAGEN N.V.
UniQure NV (UniQure)
LAVA Therapeutics N.V.
argenx SE
Arrowhead Pharmaceuticals, Inc.
Report Scope:
In this report, the Global RNA Editing Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
RNA Editing Technologies Market, By Type of RNA:
Messenger RNA Modification
Transfer RNA Modification
Ribosomal RNA Modification
RNA Editing Technologies Market, By Application:
Cancer
Genetic Disorders
Temporary Maladies
RNA Editing Technologies Market, By Technique:
Insertion/Deletion
Deamination
RNA Editing Technologies Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global RNA Editing Technologies Market.
Available Customizations:
Global RNA Editing Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global RNA Editing Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of RNA (Messenger RNA Modification, Transfer RNA Modification, Ribosomal RNA Modification)
5.2.2. By Application (Cancer, Genetic Disorders, Temporary Maladies)
5.2.3. By Technique (Insertion/Deletion, Deamination)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America RNA Editing Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of RNA
6.2.2. By Application
6.2.3. By Technique
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States RNA Editing Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of RNA
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.2. Canada RNA Editing Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of RNA
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.3. Mexico RNA Editing Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of RNA
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
7. Europe RNA Editing Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of RNA
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany RNA Editing Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of RNA
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.2. France RNA Editing Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of RNA
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.3. United Kingdom RNA Editing Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of RNA
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.4. Italy RNA Editing Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of RNA
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.5. Spain RNA Editing Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of RNA
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
8. Asia Pacific RNA Editing Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of RNA
8.2.2. By Application
8.2.3. By Technique
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China RNA Editing Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of RNA
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.2. India RNA Editing Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of RNA
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.3. Japan RNA Editing Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of RNA
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.4. South Korea RNA Editing Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of RNA
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.5. Australia RNA Editing Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of RNA
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
9. Middle East & Africa RNA Editing Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of RNA
9.2.2. By Application
9.2.3. By Technique
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia RNA Editing Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of RNA
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.2. UAE RNA Editing Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of RNA
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.3. South Africa RNA Editing Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of RNA
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
10. South America RNA Editing Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of RNA
10.2.2. By Application
10.2.3. By Technique
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil RNA Editing Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of RNA
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.2. Colombia RNA Editing Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of RNA
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.3. Argentina RNA Editing Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of RNA
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global RNA Editing Technologies Market: SWOT Analysis
